LIPUM AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.2 SEK | -6.82% |
|
-6.29% | +25.77% |
| 06-18 | Lipum AB Completes Multiple Dose Part of the Phase I Clinical Study | CI |
| 05-28 | Lipum AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 16.41M | - | - | - | - | - | |
| 95.18B | ||||||
| 37.55B | ||||||
| 33.75B | ||||||
| 28.2B | ||||||
| 15.63B |
- Stock Market
- Equities
- LIPUM Stock
- Charts Lipum AB
- Sector Chart
